All articles by Vijay Madhukar Singavarapu

  1. M&As this week: AngioDynamics, Johnson & Johnson Medical, Stryker

    AngioDynamics has entered an agreement to acquire RadiaDyne for an undisclosed sum. The transaction will add RadiaDyne’s OARtrac® device and…
    Read More…

    21 Sep
  2. Deals this week: SpineEx, Second Sight Medical Products, AtaCor Medical

    SpineEx has filed a registration statement with the US Securities and Exchange Commission (SEC) to raise $17m through an initial…
    Read More…

    21 Sep
  3. Deals this week: GE Global Research, Thermo Fisher Scientific, Bio2 Technologies

    GE Global Research, a subsidiary of General Electric (GE), has partnered with Defense Advanced Research Projects Agency (DARPA) for a…
    Read More…

    14 Sep
  4. M&As this week: BTG, Boston Scientific, LimaCorporate

    BTG has completed the acquisition of Novate Medical and will add the vascular device Sentry to its portfolio. Sentry is…
    Read More…

    14 Sep
  5. Deals this week: Body Vision Medical, Attune Medical, Miracor Medical

    Medical devices and software services provider Body Vision Medical has raised $8.5m through a financing round led by the company’s…
    Read More…

    7 Sep
  6. M&As this week: Stryker, Syneron Candela, CHF Solutions

    Stryker has signed a definitive merger agreement to acquire all outstanding shares of K2M Group, valued at $1.4bn. K2M will…
    Read More…

    7 Sep
  7. Deals this week: Exagen Diagnostics, GN Hearing, AngioDynamics

    Exagen Diagnostics and CareFirst BlueCross BlueShield have signed a development agreement to clinically study the former’s AVISE Lupus diagnostic test….
    Read More…

    24 Aug
  8. Deals and M&As this week: Siemens, Boston Scientific

    German healthcare firm Siemens has formed a strategic collaboration with NuVasive to develop novel technologies for spine surgery procedures. The…
    Read More…

    17 Aug
  9. M&As this week: Boston Scientific, Lincare Holdings

    US-based Boston Scientific has completed the acquisition of Claret Medical for $270m. Claret Medical will receive $220m in cash from Boston…
    Read More…

    10 Aug
  10. Deals this week: ReShape Lifesciences, CALCIVIS

    ReShape Lifesciences Inc has raised $0.6m through the private placement of shares of its common stock priced at $0.6 each….
    Read More…

    10 Aug
Close
Close
Close

Go Top